Cytidine / inflammation

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

FIELD OF THE INVENTION This invention relates generally to pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine and orotate, and to the prophylactic and therapeutic uses of these compounds. The invention also relates to the administration of these compounds, alone or in

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

FIELD OF THE INVENTION This invention relates generally to pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine and orotate, and to the prophylactic and therapeutic uses of these compounds. The invention also relates to the administration of these compounds, alone or in

Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

FIELD OF THE INVENTION This invention relates generally to pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine and orotate, and to the prophylactic and therapeutic uses of these compounds. The invention also relates to the administration of these compounds, alone or in

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

FIELD OF THE INVENTION This invention relates generally to pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine and orotate, and to the prophylactic and therapeutic uses of these compounds. The invention also relates to the administration of these compounds, alone or in

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

FIELD OF THE INVENTION This invention relates generally to pyrimidine nucleotide precursors including acyl derivatives of cytidine, uridine and orotate, and to the prophylactic and therapeutic uses of these compounds. The invention also relates to the administration of these compounds, alone or in

Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to an active agent of the formula I and to treating a disorder associated in part with the overexpression of cytidine deaminase or deoxycytidine deaminase, comprising administering

Synthesis of 2'-deoxy-2'-[.sup.18F]fluoro-5-methyl-1-B-D-arabinofuranosyluracil (.sup.18F-FMAU)

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

FIELD OF INVENTION This invention relates to the synthesis of .sup.18F-FMAU. More specifically, the invention provides a method for the synthesis of .sup.18F-FMAU, using one-pot reaction conditions. The one-pot synthesis conditions can be incorporated into a fully automated Current Good

cytidine/inflammation

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis

Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase

Synthesis of 2'-deoxy-2'-[.sup.18F]fluoro-5-methyl-1-B-D-arabinofuranosyluracil (.sup.18F-FMAU)

科学に裏打ちされた最も完全な薬草データベース